N
HAE icon

Natixis’s Haemonetics HAE Stock Holding History

Natixis’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,600
Closed -$1.44M – 1201
2025
Q3 		$1.44M Buy
+29,600
New +$1.83M 0.01% 618
2024
Q4 		– Sell
-1
Closed -$80 – 1110
2024
Q3 		$80 Hold
1
– – ﹤0.01% 934
2024
Q2 		$83 Hold
1
– – ﹤0.01% 964
2024
Q1 		$85 Buy
+1
New +$78 ﹤0.01% 979
2021
Q1 		– Sell
-2,795
Closed -$332K – 1114
2020
Q4 		$332K Sell
2,795
-964
-26% -$104K ﹤0.01% 945
2020
Q3 		$328K Sell
3,759
-1,289
-26% -$113K ﹤0.01% 650
2020
Q2 		$452K Sell
5,048
-46
-0.9% -$4.65K ﹤0.01% 627
2020
Q1 		$508K Sell
5,094
-4,626
-48% -$502K ﹤0.01% 569
2019
Q4 		$1.11M Buy
9,720
+1,519
+19% +$184K 0.01% 643
2019
Q3 		$1.03M Buy
8,201
+990
+14% +$126K 0.01% 587
2019
Q2 		$868K Sell
7,211
-2,512
-26% -$247K 0.01% 554
2019
Q1 		$833K Sell
9,723
-91
-0.9% -$8.28K 0.01% 610
2018
Q4 		$982K Buy
9,814
+574
+6% +$60.3K 0.01% 518
2018
Q3 		$1.06M Sell
9,240
-5,397
-37% -$559K 0.01% 563
2018
Q2 		$1.31M Sell
14,637
-699
-5% -$59K 0.01% 574
2018
Q1 		$1.12M Buy
15,336
+2,886
+23% +$198K 0.01% 573
2017
Q4 		$723K Sell
12,450
-908
-7% -$47.8K 0.01% 547
2017
Q3 		$599K Buy
+13,358
New +$555K 0.01% 619
2017
Q2 		– Sell
-5,684
Closed -$231K – 886
2017
Q1 		$231K Buy
5,684
+109
+2% +$4.26K ﹤0.01% 834
2016
Q4 		$224K Buy
+5,575
New +$210K ﹤0.01% 765

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Natixis's HAE Position: Q4 2025 in Review

Natixis sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 29,600 shares — an estimated $1.44M sold.

Natixis first reported a position in HAE in Q4 2016 and held it in 20 quarters. The position peaked at $1.44M in Q3 2025. 328 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • Natixis reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • Natixis sold 29,600 Haemonetics shares in Q4 2025, an estimated $1.44M.
  • Natixis first reported a position in Haemonetics in Q4 2016 and held it in 20 quarters.
  • Natixis's Haemonetics position peaked at $1.44M in Q3 2025.
  • 328 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on Natixis's 13F filing for Q4 2025, filed 13 Feb 2026.